Human Immunodeficiency Virus Reverse Transcriptase and Protease Sequence Database: an expanded data model integrating natural language text and sequence analysis programs.
about
Patient-specific simulation as a basis for clinical decision-makingA look inside HIV resistance through retroviral protease interaction mapsTransmission patterns of HIV-subtypes A/AE versus B: inferring risk-behavior trends and treatment-efficacy limitations from viral genotypic data obtained prior to and during antiretroviral therapyComparable long-term efficacy of Lopinavir/Ritonavir and similar drug-resistance profiles in different HIV-1 subtypesHuman immunodeficiency virus reverse transcriptase and protease sequence databaseDiscrepant results in the interpretation of HIV-1 drug-resistance genotypic data among widely used algorithms.Purifying selection masks the mutational flexibility of HIV-1 reverse transcriptase.Adaptation to different human populations by HIV-1 revealed by codon-based analysesEstimating the individualized HIV-1 genetic barrier to resistance using a nelfinavir fitness landscapeGenotypic testing for human immunodeficiency virus type 1 drug resistance.Mutation D30N is not preferentially selected by human immunodeficiency virus type 1 subtype C in the development of resistance to nelfinavir.Investigation of Super Learner Methodology on HIV-1 Small Sample: Application on Jaguar Trial Data.Origin of human immunodeficiency virus type 1 quasispecies emerging after antiretroviral treatment interruption in patients with therapeutic failure.HIV sequence databasesA Guide to HIV-1 Reverse Transcriptase and Protease Sequencing for Drug Resistance Studies.Sequence quality analysis tool for HIV type 1 protease and reverse transcriptase.Crystal structures of a multidrug-resistant human immunodeficiency virus type 1 protease reveal an expanded active-site cavity.The Genetic Basis of HIV-1 Resistance to Reverse Transcriptase and Protease Inhibitors.Directly administered antiretroviral therapy for HIV-infected drug users does not have an impact on antiretroviral resistance: results from a randomized controlled trialMechanism of HIV antiretroviral drugs progress toward drug resistance.Possible footprints of APOBEC3F and/or other APOBEC3 deaminases, but not APOBEC3G, on HIV-1 from patients with acute/early and chronic infections.Variants other than aspartic acid at codon 69 of the human immunodeficiency virus type 1 reverse transcriptase gene affect susceptibility to nuleoside analogs.A genotyping study of human immunodeficiency virus type-1 drug resistance in a small Brazilian municipality.Binding modes of two novel non-nucleoside reverse transcriptase inhibitors, YM-215389 and YM-228855, to HIV type-1 reverse transcriptase.Natural variation of drug susceptibility in wild-type human immunodeficiency virus type 1HIV-1 subtype C reverse transcriptase and protease genotypes in Zimbabwean patients failing antiretroviral therapy.Direct monthly highly active antiretroviral therapy supply - a method to increase patient's adherence and outcome. Experience of one AIDS centre in Israel.Comparison of virtual phenotype and HIV-SEQ program (Stanford) interpretation for predicting drug resistance of HIV strains.Emerging trends of drug-resistant HIV-1 among drug-treated patients in former blood donors in Hubei, China: a three-year surveillance from 2004 to 2006.Extent of human immunodeficiency virus type 1 drug resistance as a predictor of virological failure after genotype-guided treatment switch.Estimation of an in vivo fitness landscape experienced by HIV-1 under drug selective pressure useful for prediction of drug resistance evolution during treatment.Antiretroviral resistance in HIV-1 patients at a tertiary medical institute in Saudi Arabia: a retrospective study and analysis
P2860
Q28284852-6E1CE557-F14F-4136-8C87-7157200B6ED4Q28469157-860FDB44-27C6-4A19-9CCA-588698EE9053Q28487475-E5A399EE-BD31-4EAE-87DF-327593AC015FQ28539169-A878B588-8636-4C06-A78A-68B2F8FD728DQ29616403-8992B34E-3D01-4D11-96B7-084546905757Q30762478-A2622BED-91DB-4CCB-9D98-A28A21E70CF3Q33199293-4E1E0933-A33D-4DA8-BCC5-C630D0DA0C91Q33247450-89C32C52-6FC6-4847-B4AE-A84145BBB729Q33648513-657C5A30-EA72-4794-A6BB-71A38A3DC686Q33906239-0220ACF2-A038-4433-822D-6FD29AC3FB02Q34140913-806098D4-9882-4143-B7D8-C96CD7ED02E0Q34253401-12B1F8C8-6216-4099-A0AD-30FB3C1DE536Q34342200-1E68BB46-510A-417D-BD49-BC602099E3F7Q35182711-40BF365A-11E1-450C-985E-9CA631637E2CQ35742512-ADA1B328-6DE0-4EFA-B88E-71AF19D3A2AAQ36102542-AB67248D-4943-475E-A98C-570063EED314Q36529238-9E7F7579-89FE-4C2E-A541-1EBFA84E2945Q37018369-9208FBD8-19F8-413A-932C-896718FF7FAFQ37197054-ADF46A96-12B9-4889-9092-91D3B5DCE36AQ37961181-16BD9449-3C03-4C3D-BD33-F60A9983ACD4Q38879828-7D929C0C-398A-464D-A058-F67CAD689CE9Q39477972-94031DDA-E947-45D7-85DB-4815FA1D0524Q39743833-515768BA-2B92-48B8-BD2E-E579DE1B1028Q39913681-8B469682-2801-4D27-AC39-EC464BF7FF34Q40469287-0718A0A8-3C4E-4DCF-9069-BD00EEBF5AA1Q41765940-11A3D00F-A4EF-4C02-AEDF-111BD84F03E8Q42248267-1252A827-C9F1-470C-95DE-CB4D5249235AQ44078237-A25314A8-AA06-4528-960B-848D32E94EC8Q44615578-5F37EFEE-DD3D-498B-BB91-E1A8548B4486Q45736222-95FB23C5-F512-4227-83B4-F8419E497FD8Q46891926-CBAAB8F3-5170-4CD1-957E-9AB0E490D5DCQ57167106-438A5283-096A-44EA-9AFE-FAC0D6DCEB52
P2860
Human Immunodeficiency Virus Reverse Transcriptase and Protease Sequence Database: an expanded data model integrating natural language text and sequence analysis programs.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Human Immunodeficiency Virus R ...... nd sequence analysis programs.
@ast
Human Immunodeficiency Virus R ...... nd sequence analysis programs.
@en
type
label
Human Immunodeficiency Virus R ...... nd sequence analysis programs.
@ast
Human Immunodeficiency Virus R ...... nd sequence analysis programs.
@en
prefLabel
Human Immunodeficiency Virus R ...... nd sequence analysis programs.
@ast
Human Immunodeficiency Virus R ...... nd sequence analysis programs.
@en
P2093
P2860
P356
P1476
Human Immunodeficiency Virus R ...... nd sequence analysis programs.
@en
P2093
P2860
P304
P356
10.1093/NAR/29.1.296
P407
P577
2001-01-01T00:00:00Z